|
|
||||||||
Brief Report |
Received November 26, 2001; revised February 20, 2002; accepted February 20, 2002. From the Departments of Psychiatry and Pathology, The Mount Sinai School of Medicine, New York, NY (MS,AMB,DM,RCM,KLD); the Department of Psychiatry, Beth Israel Medical Center (MS); the Psychiatry Service, Bronx Veterans Affairs Medical Center, Bronx, NY (AMB,RCM); and the Jewish Home and Hospital, New York (ML). Dr. Richard Mohs is affiliated with Eli Lilly & Co., and is a Visiting Professor in the Department of Psychiatry. Mount Sinai School of Medicine. Address correspondence to Dr. Serby, Department of Psychiatry, Beth Israel Medical Center, First Avenue at 16th Street, New York, NY 10003.
Objectives: Authors compared the degrees of cognitive deficit among individuals with Alzheimer disease (AD), the Lewy-body variant of AD (LBV), and "pure" dementia with Lewy bodies (DLB); and compared cortical Lewy body (LB) counts in LBV versus DLB and neuritic plaque and neurofibrillary tangle severity in LBV versus AD. Methods: Authors examined brain specimens from consecutive autopsies of elderly nursing home subjects. Numbers and densities of plaques, Lewy bodies, and tangle severity were determined in multiple cortical regions, and demographic and clinical variables were compared among the three groups. Results: The three groups did not differ in demographic or clinical variables. The LBV group was significantly more impaired than the other groups. Cortical LB counts were significantly higher in LBV than in DLB. There was no evidence of increased plaque or tangle severity in LBV than in AD. Conclusion: The co-occurrence of AD and LB pathology is associated with higher numbers of LBs and more severe dementia than when classical AD or LB lesions occur alone.
Key Words: Alzheimer's Disease Lewy-Body Disease Cognition
This article has been cited by other articles:
![]() |
M. S. Beeri, M. Rapp, J. M. Silverman, J. Schmeidler, H. T. Grossman, J. T. Fallon, D. P. Purohit, D. P. Perl, A. Siddiqui, G. Lesser, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers Neurology, May 9, 2006; 66(9): 1399 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Holtzer, M. C. Irizarry, J. Sanders, B. T. Hyman, D. J. Wegesin, A. Riba, J. Brandt, M. Albert, and Y. Stern Relation of Quantitative Indexes of Concurrent {alpha}-Synuclein Abnormalities to Clinical Outcome in Autopsy-Proven Alzheimer Disease Arch Neurol, February 1, 2006; 63(2): 226 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Rapp, M. Schnaider-Beeri, H. T. Grossman, M. Sano, D. P. Perl, D. P. Purohit, J. M. Gorman, and V. Haroutunian Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression Arch Gen Psychiatry, February 1, 2006; 63(2): 161 - 167. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ALL ISSUES | SEARCH | TABLE OF CONTENTS |